186 related articles for article (PubMed ID: 37345307)
1. Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia.
Wang Y; Cheng W; Zhang Y; Zhang Y; Sun T; Zhu Y; Yin W; Zhang J; Li J; Shen Y
Clin Transl Med; 2023 Jun; 13(6):e1309. PubMed ID: 37345307
[TBL] [Abstract][Full Text] [Related]
2. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Eckardt JN; Stasik S; Röllig C; Petzold A; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Oelschlägel U; Berdel WE; Ehninger G; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Dahl A; Schetelig J; Bornhäuser M; Middeke JM; Thiede C
Leukemia; 2023 Dec; 37(12):2395-2403. PubMed ID: 37833543
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087
[TBL] [Abstract][Full Text] [Related]
4. The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia.
Zhang X; Zhang X; Li X; Lv Y; Zhu Y; Wang J; Jin J; Yu W
J Hematol Oncol; 2020 Oct; 13(1):140. PubMed ID: 33081843
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of IKZF1 mutation in acute myeloid leukemia.
Zhang X; Huang A; Liu L; Qin J; Wang C; Yang M; Lou Y; Wang L; Ni X; Hu X; Tang G; Zhang M; Cao S; Mao L; Qian J; Xu W; Wei J; Xu G; Meng H; Mai W; Yang C; Zhu H; Tong H; Yang J; Yu W; Wang J; Jin J
Exp Hematol Oncol; 2023 Mar; 12(1):33. PubMed ID: 36997950
[TBL] [Abstract][Full Text] [Related]
7. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
8. Ikaros and leukaemia.
Olsson L; Johansson B
Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
[TBL] [Abstract][Full Text] [Related]
9. Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.
de Rooij JD; Beuling E; van den Heuvel-Eibrink MM; Obulkasim A; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Gibson BE; Pieters R; Zimmermann M; Zwaan CM; Fornerod M
Haematologica; 2015 Sep; 100(9):1151-9. PubMed ID: 26069293
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
[TBL] [Abstract][Full Text] [Related]
12. A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network.
Unnikrishnan A; Guan YF; Huang Y; Beck D; Thoms JA; Peirs S; Knezevic K; Ma S; de Walle IV; de Jong I; Ali Z; Zhong L; Raftery MJ; Taghon T; Larsson J; MacKenzie KL; Van Vlierberghe P; Wong JW; Pimanda JE
Nucleic Acids Res; 2016 Dec; 44(22):10644-10661. PubMed ID: 27604872
[TBL] [Abstract][Full Text] [Related]
13. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
[TBL] [Abstract][Full Text] [Related]
14. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
[TBL] [Abstract][Full Text] [Related]
15. Impaired tissue homing by the Ikzf3
Chang J; Yamashita M; Padhi AK; Zhang KYJ; Taniuchi I
Front Immunol; 2023; 14():1239779. PubMed ID: 37662955
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia.
Wang T; Hua H; Wang Z; Wang B; Cao L; Qin W; Wu P; Cai X; Chao H; Lu X
Hematology; 2022 Dec; 27(1):994-1002. PubMed ID: 36066283
[TBL] [Abstract][Full Text] [Related]
17. EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.
Lavallée VP; Gendron P; Lemieux S; D'Angelo G; Hébert J; Sauvageau G
Blood; 2015 Jan; 125(1):140-3. PubMed ID: 25331116
[TBL] [Abstract][Full Text] [Related]
18. [Transcriptome sequencing-based classification and quantification of IKZF1 transcript isoforms in B-cell acute lymphoblastic leukemia].
Cao PX; Zhang GS; Wang F; Chen X; Zhang Y; Wang MY; Zhou XS; Nie DJ; Chen JQ; Ma XL; Fang JC; Liu M; Wu QS; Liu HX
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):926-933. PubMed ID: 33789373
[No Abstract] [Full Text] [Related]
19. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
20. The functional polymorphisms of ARID5B and IKZF1 are associated with acute myeloid leukemia risk in a Han Chinese population.
Cao S; Yang J; Qian X; Jin G; Ma H
Gene; 2018 Mar; 647():115-120. PubMed ID: 29292192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
